1 F.1 Introduction
It is easily understood that behavioral psychopharmacologies faced with the task of dealing with extremely complex behavioral disturbances. This holds true for both patient groups: young people with learning and memory problems and elderly patients with memory deficits. For the elderly, difficulties arise in designing appropriate animal models of human aging or the deficits occurring during human aging. One of the major problems for experimental behavioral pharmacology is whether or not old animals are the appropriate models. At the first view it seems obvious that the study of potential geronto-psychopharmacologic drugs should be performed in old animals. However, the problem is much more complicated. Laboratory animals are not a homogenous population, especially when old. Most of these old animals who are one third survivors of a population have an individually different pathological history which is mostly unknown to the investigators. Some animals may be...
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
1Contribution by E. Dere.
References
References
Abe K, Takeyama C, Yoshimura K (1998) Effects of S-8510, a novel benzodiazepine receptor partial inverse agonist, on basal forebrain lesioning-induced dysfunction in rats. Eur J Pharmacol 347:145–152
Alvarez P, Zola-Morgan S, Squire LR (1994) The animal model of human amnesia: Long-term memory impaired and short-term memory intact. Proc Natl Acad Sci USA 91:5637–5641
Bartus RT, Dean RL, Beer B (1980) Memory deficits in aged Cebus monkeys and facilitation with central cholinomimetics. Neurobiol Aging 1:145–152
Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–417
Bartus RT, Dean RL, Flicker C (1987) Cholinergic psychopharmacology: an integration of human and animal research on memory. In: Meltzer HY (ed) Psychopharmacology: The Third Generation of Progress. Raven Press, New York, pp 219–232
Beers DR, Henkel JS, Kesner RP, Stroop WG (1995) Spatial recognition memory deficits without notable CNS pathology in rats following herpes simplex encephalitis. J Neurol Sci 131:119–127
Bjugstad KB, Flitter WD, Garland WA, Su GC, Arendash GW (1998) Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia. Brain Res 795:349–357
Campbell BA, Spear NE (1972) Ontogeny of memory. Psychol Rev 79:215–236
Carli M, Bonalumi P, Samanin R (1997) Way 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid. Brain Res 774:167–174
Chambers RA, Moore J, McEnvoy JP, Levin ED (1996) Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology 15:587–594
Changeux JP, Bertrand D, Corringer PJ, Dehaene S, Edelstein S, Léna C, LeNovère N, Marubio L, Picciotto M, Zoli M (1998) Brain nicotinic receptors: structure and regulation, role in learning and reinforcement. Brain Res Rev 26:198–216
Chapman S, Fisher A, Weinstock M, Brandies R, Shohami E, Michaelson DM (1998) The effects of the acetylcholinesterase inhibitor ENA713 and the M1 agonist AF 150(S) on apolipoprotein E deficient mice. J Physiol (Paris) 92:34
Chen Z, Sugimoto Y, Kamei C (1997) Effects of histamine and its related compounds on impairment of passive avoidance response following hippocampal lesions in rats. J Brain Sci 23:225–240
Christie JE, Shering A, Ferguson J, Glen AIM (1981) Physostigmine and aerocline: Effects of intravenous infusions in Alzheimer presenile dementia. Br J Psychiatry 138:46–50
Craik FJM (1977) Age differences in human memory. In: Birren JE, Schaie KW (eds) Handbook of the Psychobiology of Aging, Von Nostrand Reinhold Co., New York, NY, pp 384–420
Davis KL, Mohs RC (1982) Enhancement of memory processes in Alzheimer's disease with multiple dose intravenous physostigmine. Am J Psychiatry 139:1421–1424
English JA, Hemphill KM, Paul IA (1998) LP-BM5 infection impairs acquisition, but not performance, of active avoidance responding in C57B/6 mice. FASEB J 12:175–179
Ennaceur A (1998) Effects of lesions of the Substantia Innominata/Ventral Pallidum, Globus Pallidus and Medial Septum on rat's performance in object-recognition and radial-maze tasks: Physostigmine and amphetamine. Pharmacol Res 38:251–263
Enz A, Boddeke H, Sauter A, Rudin M, Shapiro G (1993) SDZ ENS 163 a novel pilocarpin like drug: pharmacological in vitro and in vivo profile. Life Sci 52:513–520
Fernandez-Ruiz J, Doudet DJ, Aigner TG (1995) Long-term cognitive impairment in MPTP-treated rhesus monkeys. Neuro-Report 7:102–104
Fisher A, Hanin I (1986) Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity. Ann Rev Pharmacol Toxicol 26:161–181
Flood JF, Morley JE (1998) Learning and memory in the SAMP8 mouse. Neurosci Biobehav Rev 22:1–20
Fox GB, Faden AI (1998) Traumatic brain injury causes delayed motor and cognitive impairment in a mutant mouse strain known to exhibit delayed Wallerian degeneration. J Neurosci Res 53:718–727
Fujibayashi Y, Waki A, Wada K, Ueno M, Magata Y, Yonekura Y, Konishi J, Takedaa T, Yokoyama A (1994) Differential aging pattern of cerebral accumulation of radiolabeled glucose and amino acid in the senescence accelerated mouse (SAM), a new model for the study of memory impairment. Biol Pharm Bull 17:102–105
Gaffan D (1994) Scene-specific memory for objects: A model of episodic memory impairment in monkeys with fornix transection. J Cogn Neurosci 6:305–320
Gahtan E, Auerbach JM, Groner Y, Segal M (1998) Reversible impairment of long-term potentiation in transgenic Cu/Zn-SOD mice. Eur J Neurosci 10:538–544
Gervais-Fagnou DD, Tuchek JM (1996) Learning impairment in 1–2 day-old chicks. Epilepsia 37:322–327
Giurgea C, Mouravieff-Lesiusse F (1971) Pharmacological studies on an elementary model of learning — The fixation of an experience at spinal level: Part I: Pharmacological reactivity of the spinal cord fixation time. Arch Int Pharmacodyn 191:279–291
Giurgea C, Salama M (1977) Nootropic drugs. Progr Neuro-Psychopharmac 1:235–247
Gold PE, McGaugh JL (1975) Changes in learning and memory during aging, In: Ordy JM, Brizzee KR (eds) Neurobiology of Aging, Plenum Press, New York, NY, pp 145–158
Gold PE, van Buskirk RB, McGaugh JL (1975) Age-related changes in learning and memory. In: Maletta G (ed), A Survey Report on the Aging Nervous System, US Government Printing Office, Washington, DC, pp 169–178
Harder JA, Maclean CJ, Alder JT, Francis PT, Ridley RM (1996) The 5-HT1A antagonist, Way 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset. Psychopharmacology 127:245–254
Hess EH (1972) “Imprinting” in a natural laboratory. Scientific American 227:24–31
Hock FJ (1987) Drug influences on learning and memory in aged animals and humans. Neuropsychobiol 17:145–160
Inagawa K (1994) Impairment of spatial working memory of rats in radial maze performance induced by ethylcholine mustard aziridinium picrylsulfonate (AF6P-P): Retention curve analysis. Jpn J Psychopharmacol 14:9–17
Ishikawa K, Kubo T, Shibanoki S, Matsumoto A, Hata H, Asai S (1997) Hippocampal degeneration inducing impairment of learning in rats: Model of dementia? Behav Brain Res 83:39–44
Jarvik ME (1964) Techniques for evaluating the effects of drugs on memory. In: Nodin JH, Siegler PE (eds) Animal and Clinical Pharmacologic Techniques in Drug Evaluation. Year Book Medical Publ, Inc.; Chicago, pp 339–347
Kubanis P, Zornetzer SF (1981) Age-related behavioral and neurobiological changes: A review with emphasis on memory. Behav neural Biol 31:115–172
Lennenberg E (1967) The Biological Foundations of Language. Wiley & Sons, New York, NY
Markowska AL, Spangler EL, Ingram DK (1998) Behavioral assessment of the senescence-accelerated mouse (SAM P8 and R1) Physiol Behav 64:15–26
Maurice T, Roman FJ, Su T-P, Privat A (1996) Beneficial effects of sigma agonists on the age-related learning impairment in the senescence-accelerated mouse (SAM). Brain Res 733:219–230
Misztal M, Skangiel-Kramska J, Niewiadomska G, Danysz W (1996) Subchronic intraventricular infusion of quinolinic acid produces working memory impairment. A model of progressive excitotoxicity. Neuropharmacology 35:449–458
Nishiyama N, Moriguchi T, Saito H (1997) Beneficial effects of aged garlic extract on learning and memory impairment in the senescence-accelerated mouse. Exp Gerontol 32:149–160
Nitta A, Ogihara Y, Onishi J, Hasegawa T, Furukawa S, Nabeshima T (1997) Oral administration of propentofylline, a stimulator of nerve growth factor (NGF) synthesis, recovers cholinergic neuronal dysfunction induced by the infusion of anti-NGF antibody into the rat septum. Behav Brain Res 83:201–204
Nordberg A (1990) Pharmacological modulation of transmitter activity in Alzheimer brains — an experimental model. In: Novel Therapeutic Strategies for Dementia Diseases. Acta Neur Scand, Suppl 129:17–20
Roder JK, Roder JC, Gerlai R (1996) Memory and the effect of cold shock in the water maze in S100β transgenic mice. Physiol Behav 60:611–615
Scheich H (1987) Neural correlates of auditory filial imprinting. J Comp Physiol A 161:605–619
Schindler U, Rush DK, Fielding S (1984) Nootropic drugs: Animal models for studying effects on cognition. Drug Devel Res 4:567–576
Stancheva S, Papazova M, Alova L, Lazarova-Bakarova M (1993) Impairment of learning and memory in shuttle-box trained rats neonatally injected with 6-hydroxydopamine. Effect of nootropic drugs. Acta Physiol Pharmacol Bulg 19:77–82
Summers WE, Viesselman JO, March GM, Candelora K (1981) Use of THA in treatment of Alzheimer-like dementia. Pilot study in twelve patients. Biol Psychiatry 16:145–153
Sunderland T, Tariot PN, Newhouse PA (1988) Differential responsitivity of mood, behavior, and cognition to cholinergic agents in elderly, neuropsychiatric populations. Brain Res Rev 13:371–389
Takeda T (1996) Senescence-accelerated mouse (SAM): With special reference to age-associated pathologies and their modulation. Jpn J Hyg 51:569–578
Takeda T, Hosokawa M, Higuchi K, Hosono M, Akiguchi I, Katoh H (1994) A murine model of aging, Senescence-Accelerated Mouse. Arch Gerontol Geriatr 19:185–192
Takeda T, Matsushita T, Kurozumi M, Takemura K, Higuchi K, Hosokawa M (1997) Pathobiology of the senescence-accelerated mouse (SAM). Exper Gerontol 32:117–127
Thal LJ, Fuld PA, Masur DM, Sharpless NS (1983) Oral physostigmine and lecithin improve memory in Alzheimer's disease. Ann Neurology 13:491–496
Thompson G (1983) Rodent models of learning and memory in aging research. In Walker RF, Cooper RL (eds) Experimental and Clinical Interventions in Aging. Marcel Dekker, Inc., New York and Basel, pp 261–278
Tienari PJ, de Strooper B, Ikonen E, Ida N, Simons M, Masters CL, Dotti CG, Bayreuther K (1996) Neuronal sorting and processing of amyloid precursor protein: Implications for Alzheimer's disease. Cold Spring Harbor Symposia on Quantitative Biology 61:575–585
Tremml P, Lipp HP, Müller U, Ricceri L, Wolfer DP (1998) Neurobehavioral development, adult open field exploration and swimming navigation learning in mice with a modified β-amyloid precursor protein gene. Behav Brain Res 95:65–76
Weidemann A, König G, Bunke D, Fischer P, Salbaum JM, Masters CL, Beyreuther K (1989) Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57:115–126
Ye W-Y, Cai J-X, Wang L-M, Tang X-C (1999) Improving effects of huperizine A on spatial working memory in aged monkeys and in young adult monkeys with experimental cognitive impairment. J Pharmacol Exp Ther 288:814–819
Yu Z, Cheng G, Hu B (1997) Mechanism of colchicine impairment of learning and memory, and protective effect of CGP-36742 in mice. Brain Res 750:53–58
References
Atak JR, Perry EK, Bonham JR, Perry RH, Tomlinson BE, Blessed G, Fairbairn A (1983) Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form. Neurosci Lett 40:199–204
Augustinsson KB (1971) Determination of activity of cholinesterases. In: Glick D (ed) Methods of Biochemical Analysis, John Wiley & Sons, New York, pp 217–273
Chan SL, Shirachi DY, Bhargava HN, Gardner E, Trevor AJ (1972) Purification and properties of multiple forms of brain acetylcholinesterase. J Neurochem 19:2747–2758
Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K i) and the concentration of inhibitor which causes 50 percent inhibition (IC 50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Christie JE, Shering A, Ferguson J, Glen AIM (1981) Physostigmine and arecoline: Effects of intravenous infusions in Alzheimer presenile dementia. Br J Psychiatry 138:46–50
Davis KL, Mohs RC (1982) Enhancement of memory processes in Alzheimer's disease with multiple dose intravenous physostigmine. Am J Psychiatry 139:1421–1424
Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
Grassi J, Vigny M, Massoulié J (1982) Molecular forms of acetylcholinesterase in bovine caudate nucleus and superior cervical ganglion: solubility properties and hydrophobic character. J Neurochem 38:457–469
Koelle GB, Koelle FS, Friedenwald JS (1950) The effect of inhibition of specific and non-specific cholinesterases. J Pharmacol Exp Ther 100:180–191
McIntosh CHS, Plummer DT (1973) Multiple forms of acetylcholinesterase from pig brain. Biochem J 133:655–665
Nachmansohn D, Rothenberg MA (1945) Studies on cholinesterase 1. On the specificity of the enzyme in nerve tissue. J Biol Chem 158:653–666
Rieger F, Vigny M (1976) Solubilization and physicochemical characterization of rat brain acetylcholinesterase: development and maturation of its molecular forms. J Neurochem 27:121–129
Summers WE, Viesselman JO, March GM, Candelora K (1981) Use of THA in treatment of Alzheimer-like dementia. Pilot study in twelve patients. Biol Psychiatry 16:145–153
Taylor P (1996) Anticholinesterase agents. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. McGraw-Hill, New York, pp 161–176
Thal LJ, Fuld PA, Masur DM, Sharpless NS (1983) Oral physostigmine and lecithin improve memory in Alzheimer's disease. Ann Neurology 13:491–496
Trevor AJ, Gordon MA, Parker KK, Chan SL (1978) Acetylcholinesterases. Life Sci 23:1209–1220
References
Chemnitius J-M, Haselmeyer K-H, Zech R (1983) Brain cholinesterases: Differentiation of target enzymes for toxic organophosphorus compounds. Biochem Pharmacol 32:1693–1699
Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
Walker CH, Mackness MI (1983) Esterases: Problems of identification and classification. Biochem Pharmacol 32:3265–3269
References
Christie JE, Shering A, Ferguson J, Glen AIM (1981) Physostigmine and arecoline: Effects of intravenous infusions in Alzheimer presenile dementia. Br J Psychiatry 138:46–50
Davis KL, Mohs RC (1982) Enhancement of memory process in Alzheimer's disease with multiple dose intravenous physostigmine. Am. J. Psychiatry 139:1421–1424
Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
Gouret C (1973) Etude de cinq tests rapides de sélection d'une activité anticholinergique chez la souris. J Pharmacol (Paris) 4:105–128
Heilbronn E (1961) Inhibition of cholinesterase by tetrahydroaminacrin. A Chem Scand 15:1386–1390
Muller F, Dumez Y, Massoulié J (1985) Molecular forms and solubility of acetylcholinesterase during the embryonic development of rat and human brain. Brain Res 331:295–302
O'Brien RD (1969) Phosphorylation and carbamylation of cholinesterase. Ann NY Acad Sci 160:204–214
Sivam SP, Norris JC, Lim DK, Hoskins B, Ho IK (1983) Effect of acute and chronic cholinesterase inhibition with diisopropylfluorophosphate on muscarinic, dopamine, and GABA receptors in the rat striatum. J Neurochem 40:1414–1422
Steinberg GM, Mednick ML, Maddox J, Rice R, Cramer J (1975) A hydrophobic binding site in acetylcholinesterase. J Med Chem 18:1056–1061
Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A (1986) Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. New Engl J Med 315:1241–1245
Taylor P (1996) Anticholinesterase agents. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. McGraw-Hill, New York, pp 161–176
Thal LJ, Fuld PA, Masur DM, Sharpless NS (1983) Oral physostigmine and lecithin improve memory in Alzheimer's disease. Ann Neurology 13:491–496
Yamada S, Isogai M, Okudaira H, Hayashi R (1983) Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine. J Pharmacol Exp Ther 226:519–525
References
Atack JR, Perry EK, Bonham JR, Perry RH, Tomlinson BE, Blessed G, Fairbairn A (1983) Molecular forms of acetylcholinesterase in senile dementia of the Alzheimer type: Selective loss of the intermediate (10S) form. Neurosci Lett 40:199–204
Bon S, Vigny M, Massoulié J (1979) Asymmetric and globular forms of acetylcholinesterase in mammals and birds. Proc Natl Acad Sci. USA 76:2546–2550
Bonnichsen RK, Brink NG (1955) Liver alcohol dehydrogenase. In: Colowick SP, Kaplan NO (eds) Methods of Enzymology, Vol. I, p. 241, Academic Press, New York
Ceullo AC, Sofroniew MV (1984) The anatomy of the CNS cholinergic neurons. TINS 7:74–78
Chan SL, Shirachi DY, Bhargava HN, Gardner E, Trevor AJ (1972) Purification and properties of multiple forms of brain acetylcholinesterase. J Neurochem 19:2747–2758
Chance B, Maehly AC (1955) Catalase assay by the disappearance of peroxide. In: Colowick SP, Kaplan NO (eds) Methods of Enzymology, Vol. II, pp 764–768, Academic Press, New York
Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
Grassi J, Vigny M, Massoulié J (1982) Molecular forms of acetylcholinesterase in bovine caudate nucleus and superior cervical ganglion: solubility properties and hydrophobic character. J Neurochem 38:457–469
Hestrin S, Feigold DS, Schramm M (1955) Hexose hydrolases. In: Colowick SP, Kaplan NO (eds) Methods of Enzymology, Vol. I, pp 231–257, Academic Press, New York
Lenz DE, Maxwell DM (1981) Inhibition of rat cerebrum acetylcholinesterase isozymes after acute administration of soman. Biochem Pharmacol 30:1369–1371
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J. Biol Chem 193:265–275
McIntosh CHS, Plummer DT (1973) Multiple forms of acetyl-cholinesterase from pig brain. Biochem J 133:655–665
Muller F, Dumez Y, Massoulié J (1985) Molecular forms and solubility of acetylcholinesterase during the embryonic development of rat and human brain. Brain Res 331:295–302
Reiger F, Vigny M (1976) Solubilization and physicochemical characterization of rat brain acetylcholinesterase: Development and maturation of its molecular forms. J Neurochem 27:121–129
Trevor AJ, Gordon MA, Parker KK, Chan SL (1978) Acetylcholinesterases. Life Sci 23:1209–1220
References
Damsa G, Westerink GHC, Horn AS (1985) A simple, sensitive, and economic assay for choline and acetylcholine using HPLC, an enzyme reactor, and an electrochemical detector. J Neurochem 45:1649–1652
De Belleroche JS, Gardiner IM (1982) Cholinergic action in the nucleus accumbens: Modulation of dopamine and acetylcholine release. Br J Pharmacol 75:359–365
De Boer T, Maura G, Raiteri M, de Vos CJ, Wieringa J, Pinder RM (1988) Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, ORG 3770 and its enantiomers. Neuropharmacology 27:399–408
Drukarch B, Schepens E, Schoffelmeer ANM, Stoof JC (1989) Stimulation of D-2 dopamine receptors decreases the evoked in vitro release of [3H]-acetylcholine from rat neostriatum: Role of K+ and Ca2+. J Neurochem 52:1680–1685
Gibson GE, Peterson C (1981) Aging decreases oxidative metabolism and the release and synthesis of acetylcholine. J Neurochem 37:978–984
Hadhazy P, Szerb JC (1977) The effect of cholinergic drugs on [3H] acetylcholine release from slices of rat hippocampus, striatum and cortex. Brain Res 123:311–322
Harms HH, Wardeh G, Mulder AH (1979) Effects of adenosine on depolarization-induced release of various radiolabelled neurotransmitters from slices of rat corpus striatum. Neuropharmacol 18:577–580
Israël M, Lesbats B (1982) Application to mammalian tissue of the chemoluminescent method for detecting acetylcholine. J Neurochem 39:248–250
Jackson D, Stachowiak MK, Bruno JP, Zigmond MJ (1988) Inhibition of striatal acetylcholine release by endogenous serotonin. Brain Res 457:259–266
James MK, Cubeddu LX (1984) Frequency-dependent musc arinic receptor modulation of acetylcholine and dopamine release from rabbit striatum. J Pharmacol Exp Ther 229:98–104
James MK, Cubeddu LX (1987) Pharmacological characterization and functional role of muscarinic autoreceptors in the rabbit striatum. J Pharmacol Exp Ther 240:203–214
Magnusson O, Nilsson LB, Westerlund D (1980) Simultaneous determination of dopamine, DOPC and homovanillic acid, Direct injections of supernatants from brain tissue homogenates in a liquid chromatography-electrochemical detection system. J Chromatogr 221:237–247
Muramatsu M, Tamaki-Ohashi J, Usuki C, Araki H, Aihara H (1988) Serotonin-2 receptor-mediated regulation of release of acetylcholine by minaprine in cholinergic nerve terminal of hippocampus of rat. Neuropharmacol 27:603–609
Nielsen JA, Johnston CA (1982) Rapid, concurrent analysis of dopamine, 5-hydroxytryptamine, their precursors and metabolites utilizing high performance liquid chromatography with electrochemical detection: analysis of brain tissue and cerebrospinal fluid. Life Sci 31:2847–2856
Nishino N, Fuji Y, Kondo M, Shuntoh H, Fujiwara H, Tanaka C (1987) Effects of L-Threo-3,4,-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain. J Pharmacol Exp Ther 242:621–628
Parker EM, Cubeddu LX (1986) Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. J Pharmacol Exp Ther 237:179–192
Raiteri M, Angelini F, Levi G (1974) A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol 25:411–414
Raiteri M, Marchi M, Maura G (1984) Release of catecholamines, serotonin, and acetylcholine from isolated brain tissue. In: Lajtha A (ed) Handbook of Neurochemistry, 2nd ed, Plenum Press New York, London, pp 431–462
Richardson IW, Szerb JC (1974) The release of labelled acetylcholine and choline from cerebral cortical slices stimulated electrically. Br J Pharmacol 52:499–507
Robinson S (1983) Effect of 5-HT-lesions on cholinergic neurons in the hippocampus, cortex and striatum. Life Sci 32:345–353
Saijoh K, Fujiwara H, Tanaka C (1985a) Influence of hypoxia on release and uptake of neurotransmitters in guinea pig striatal slices: Dopamine and acetylcholine. Jpn J Pharmacol 39:529–539
Saijoh K, Fujiwara H, Tanaka C (1985b) Influence of hypoxia on release and acetylation of [3H]choline in brain slices from adult and newborn guinea pigs. Neurosci Lett 58:371–374
Schacht U, Leven M, Bäcker G (1977) Studies on brain metabolism of biogenic amines. Br J Clin Pharmacol 4:77S–87S
Sethy VH, Francis JW, Russell RR, Ruppel PL (1988) Dual effect of N-methyl-N-(1-methyl-4-pyrrolidino)-2-butyl) acetamide on release of (3H) acetylcholine from the rat hippocampal slices. Neuropharmacol 27:1191–1195
Smith CP, Petko WW, Kongsamut S, Roehr JE, Effland RC, Klein HT, Huger FP (1984) Mechanisms for the increase in electrically-stimulated norepinephrine (NE) release from cortical slices by HP 749 [N-(n-propyl)-N-(4-pyridinyl)-1H-indol-1-amine]. Drug Dev Res 32:13–18
Smith CP, Huger FP, Petko W, Kongsamut S (1994a) HP 749 enhances calcium-dependent release of [3H]norepinephrine from rat cortical slices and synaptosomes. Neurochem Res 19:1265–1270
Smith CP, Petko WW, Kongsamut S, Roehr JE, Effland RC, Klein JT, Huger FP (1994b) Mechanisms for the increase in electrically stimulated [3H]norepinephrine release from rat cortical slices by N-(n-propyl)-N-(4-pyridinyl)-1H-indol-1-amine. Drug Dev Res 32:13–18
Spignoli G, Pedata F, Giovannelli L, Banfi S, Moroni F, Pepeu G (1986) Effect of oxiracetam and piracetam on central cholinergic mechanisms and active-avoidance acquisition. Clin Neuropharmacol 9:S39–S47
Stadler S, Nesselhut T (1986) Simple and rapid measurement of acetylcholine and choline by HPLC and enzymatic-electrochemical detection. Neurochem Int 9:127–129
Strittmatter H, Jackisch R, Hertting G (1982) Role of dopamine receptors in the modulation of acetylcholine release in the rabbit hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 321:195–200
Supavilai P, Karobath M (1985) Modulation of acetylcholine release from rat striatal slices by the GABA/benzodiazepine receptor complex. Life Sci 36:417–426
Szerb JC, Hadhazy P, Dudar JC (1977) Release of [3H]-acetylcholine from rat hippocampal slices: Effect of septal lesion and of graded concentrations of muscarinic agonists and antagonists. Brain Res 128:285–291
Wagner J, Palfreyman M, Zraika M (1979) Determination of DOPA, dopamine, DOPAC, epinephrine, norepinephrine, α-fluoromethylDOPA, and α-difluoromethylDOPA in various tissues of mice and rats using reversed-phase ion-pair liquid chromatography with electrochemical detection. J Chromatogr 221:237–247
Wagner J, Vitali P, Palfreyman MG, Zraika M, Huot S (1982) Simultaneous determination of 3,4-dihydroxyphenylalanine, 5-hydroxytryptophan, dopamine, 4-hydroxy-3-methoxyphenylalanine, norepinephrine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, serotonin, and 5-hydroxyindoleacetic acid in rat cerebrospinal fluid and brain by high-performance liquid chromatography with electrochemical detection. J Neurochem 38:1241–1254
Zahniser NR, Peris J, Dwoskin LP (1986) Modulation of neurotransmitter release: an assay for receptor function. In: Chemical and functional assay of receptor binding. Soc Neurosci, Short Course 1, Syllabus, Washington, DC, pp 73–81
References
Aronstam RS, Narayanan TK (1988) Temperature effect on the detection of muscarinic receptor-G protein interactions in ligand binding assays. Biochem Pharmacol 37:1045–1049
Aronstam RS, Abood LG, Hoss W (1978) Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol Pharmacol 14:575–586
Bebbington A, Brimblecombe RW, Shakeshaft D (1966) The central and peripheral activity of acetylenic amines related to oxotremorine. Br J Pharmacol 26:56–57
Birdsall NJM, Burgen ASV, Hulme EC (1978) The binding of agonists to brain muscarinic receptors. Mol Pharmacol 14:723–736
Brown JH, Brown SL (1984) Agonists differentiate muscarinic receptors that inhibit cyclic AMP formation from those that stimulate phosphoinositide metabolism. J Biol Chem 259:3777–3781
Caulfield MP (1993) Muscarinic receptors — characterization, coupling and function. Pharmacol Ther 58:319–379
Cho AK, Haslett WL, Jenden DJ (1962) The peripheral actions of oxotremorine, a metabolite of tremorine. J Pharmacol Exp Ther 138:249–257
Ehlert FJ (1985) The relationship between muscarinic receptor occupancy and adenylate cyclase inhibitor in the rabbit myocardium. Mol Pharmacol 28:410–421
El-Fakahani EE, Ramkumar V, Lai WS (1986) Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 subtypes. J Pharmacol Exp Ther 238:554–563
Fisher SK, Figueirdo JC, Bartus R.J (1984) Differential stimulation of inositol phospholipid tumover in brain by analogs of oxotremorine. J Neurochem 43:1171–1179
Hulme EC, Birdsall NJM, Burger ASV, Mehta P (1978) The binding of antagonists to muscarinic receptors. Mol Pharmacol 14:737–750
Jones SVP (1993) Muscarinic receptor subtypes: Modulation of ion channels. Life Sci 52:457–464
Luthin GR, Wolfe BB (1984) Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. J Pharmacol Exp Ther 228:648–655
Marks MJ, O'Connor MF, Artman LD, Burch JB, Collins AC (1984) Chronic scopolamine treatment and brain cholinergic function. Pharmacol Biochem Behav 20:771–777
McKinney M (1993) Muscarinic receptor subtype-specific coupling to second messengers in neuronal systems. Progr Brain Res 98:333–340
McKinney M, Coyle JT (1991) The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer's disease. Mayo Clinic Proc 66:1225–1237
Narahashi T (1992) Overview of toxins and drugs as tools to study excitable membrane ion channels: II. Transmitter activated channels. Meth Enzymol 207:643–658 Sokolovsky M, Gurwitz D, Galron R (1980) Muscarinic receptor binding in mouse brain: regulation by guanine nucleotides. Biochem Biophys Res Commun 94:487–492
Nonaka R, Moroji T (1984) Quantitative autoradiography of muscarinic cholinergic receptors in the rat brain. Brain Res 296:295–303
Olianas MC, Onali P, Neff NH, Costa E (1983) Adenylate cyclase activity of synaptic membranes from rat striatum: inhibition by muscarinic receptor agonists. Mol Pharmacol 23:393–398
Ringdahl B, Jenden DJ (1983) Minireview: Pharmacological properties of oxotremorine and its analogs. Life Sci 32:2401–2413
Smith CP, Huger FP (1983) Effect of zinc on [3H]-QNB displacement by cholinergic agonists and antagonists. Biochem Pharmacol 32:377–380
Watson M, Roeske WR, Yamamura HI (1982) [3H]Pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex. Life Sci 31:2019–2023
Watson M, Yamamura HI, Roeske WR (1983b) A unique regulatory profile and regional distribution of [3H]pirenzepine in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes. Life Sci 32:3001–3011
Wess J (1996) Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 10:69–99
References
Aronstam RS, Narayanan TK (1988) Temperature effect on the determination of muscarinic receptor-G protein interactions in ligand binding assays. Biochem Pharmacol 37:1045–1049
Gilman AG (1986) Receptor-regulated G proteins. TINS 9:460
References
Berridge MJ (1987) Inositol trisphosphate and diacylglycerol: two interacting second messengers. Ann Rev Biochem 56:159–193
Berridge MJ, Irvine RF (1984) Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312:315–321
Cockcroft S, Gomperts BD (1985) Role of guanine nucleotide binding protein in the activation of polyphosphoinositide phosphodiesterase. Nature 313:534–536
Conklin BR, Brann MR, Ma AL, Buckley NJ, Bonner TI, Axelrod J (1988) Stimulation of arachidonic acid release in transfected cells expressing cloned muscarinic receptors. Soc Neurosci Abst 14:600
Fisher SK, Agranoff BW (1987) Receptor activation and inositol lipid hydrolysis in neural tissues. J Neurochem 48:999–1017
Fisher SK, Bartus RT (1985) Regional differences in the coupling of muscarinic receptors to inositol phospholipid hydrolysis in guinea pig brain. J. Neurochem. 45:1085–1095
Fisher SK, Klinger PD, Agranoff BW (1983) Muscarinic agonist binding and phospholipid turnover in brain. J Biol Chem 258:7358–7363
Fisher SK, Figueiredo JC, Bartus RT (1984) Differential stimulation of inositol phospholipid turnover in brain by analogs of oxotremorine. J Neurochem 43:1171–1179
Fisher SK, Domask LM, Roland RM (1989) Muscarinic receptor regulation of cytoplasmic Ca2+ concentrations in human SK-N-SH neuroblastoma cells: Ca2+ requirements for phospholipase C activation. Mol Pharmacol 35:195–204
Gusovsky F, Daly JW (1988) Formation of inositol phosphates in synaptoneurosomes of guinea pig brain: stimulatory effects of receptor agonists, sodium channel agents and sodium and calcium ionophores. Neuropharmacol 27:95–105
Gusovsky F, Hollingsworth EB, Daly JW (1986) Regulation of phosphatidylinositol turnover in brain synaptoneurosomes: Stimulatory effects of agents that enhance influx of sodium ions. Proc Natl Acad Sci USA 83:3003–3007
Gusovsky F, McNeal EZ, Daly JW (1987) Stimulation of phosphoinositide breakdown in brain synaptoneurosomes by agents that activate sodium influx: antagonism by tetrodotoxin, saxitoxin, and cadmium. Mol Pharmacol 32:479–487
Heller Brown J, Brown SL (1984) Agonists differentiate muscarinic receptors that inhibit cyclic AMP formation from those that stimulate phosphoinositide metabolism. J Biol Chem 259:3777–3788
Heller Brown J, Goldstein D, Masters SB (1985) The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Mol Pharmacol 27:525–531
Hirasawa K (1985) Phospatidylinositol turnover in receptor mechanisms and signal transduction. Ann Rev Pharmacol Toxicol 25:147–170
Hirasawa K, Nishizuka Y (1985) Phosphatidylinositol turnover in receptor mechanism and signal transduction. Ann Rev Pharmacol Toxicol 25:147–170
Hokin LE and Hokin MR (1955) Effects of acetylcholine on the turnover of phosphoryl units in individual phospholipids of pancreas slices and brain cortex slices. Biochem Biophys Acta 18:102–110
McKinney M (1993) Muscarinic receptor subtype-specific coupling to second messengers in neuronal systems. In: Cuello AC (ed) Progress in Brain Research, Vol 98, Chapter 40, pp 333–340
Nahorski SR, Kendall DA, Batty I (1986) Receptors and phosphoinositide metabolism in the central nervous system. Biochem Pharmacol 35:2447–2453
Shapiro RA, Scherer NM, Habecker BA, Subers EM, Nathanson NM (1988) Isolation, sequence and functional expression of the mouse M1 muscarinic acetylcholine receptor gene. J Biol Chem 263:18397–18403
References
Alkondon M, Albuquerque EX (1993) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J Pharmacol Exp Ther 265:1455–1473
Araujo DM, Lapchak PA, Collier B, Quirion R (1988a) Characterization of N-[3H]methylcarbamylcholine on acetylcholine release in rat brain J. Neurochem 51:292–299
Araujo DM, Lapchat PA, Robitaille Y, Gauthier S, Quirion R (1988b) Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J Neurochem 50:1914–1923
Badio B, Daly JW (1994) Epibatidine, a potent analgesic and nicotinic agonist. Mol Pharmacol 45:563–569
Balfour DJK (1982) The effects of nicotine on brain neurotrans-mitter systems. Pharmacol Ther 16:269–282
Clarke PBS (1987) Nicotine and smoking: A perspective from animal studies. Psychopharmacology 92:135–143
Connolly J, Boulter J, Heinemann SF (1992) α4-β2 and other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs. Br J Pharmacol 105:657–666
Drasdo A, Caulfield M, Bertrand D, Bertrand S, Wonnacott (1992) Methyllycaconitine: a novel nicotinic antagonist. Mol Cell Neurosci 3:237–243
Gotti C, Fornasaru D, Clementi F (1997) Human neuronal nicotinic receptors. Progr Neurobiol 53:199–237
Karlin A (1991) Explorations of the nicotinic acetylcholine receptor. Harvey Lect 85:71–107
Lapchak PA, Araujo DM, Quirion R, Collier B (1989) Effect of chronic nicotine treatment on nicotinic autoreceptor function and N-[3H]methylcarbamylcholine binding sites in the rat brain. J Neurochem 52:483–491
Luetje CW, Patrick J (1991) Both α-and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci 11:837–845
Luetje CW, Wada K, Rogers S, Abramson SN, Tsuji K, Heinemann S, Patrick J (1990) Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations. J Neurochem 55:632–640
Mulle C, Vidal C, Benoit P, Changeux JP (1991) Existence of different subtypes of nicotinic acetylcholine receptors in the rat habenulo-interpeduncular system. J Neurosci 11:2588–2597
Nordberg A, Winblad B (1986) Reduced number of [3H]nicotine and [3H]-acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett 72:115–119
Pabreza LA, Dhawan S, Kellar KJ (1991) [3H]Cytisine binding to nicotinic cholinergic receptors in brain. Mol Pharmacol 39:9–12
Role LW (1992) Diversity in primary structure and function of neuronal nicotinic acetylcholine receptor channels. Curr Opin Neurobiol 2:254.262
Sargent PB (1993) The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 16:403–443
Shimohama S, Taniguchi T, Fujiwara M, Kameyama M (1986) Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia. J Neurochem 46:288–293
Sunderland T, Tariot PN, Newhouse PA (1988) Differential responsivity of mood, behavior and cognition to cholinergic agents in elderly neuropsychiatric populations. Brain Res Rev 13:371–389
Vernalllis AB, Conroy WG, Berg DK (1993) Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes. Neuron 10:451–464
Whitehouse PJ, Martino AM, Wagster MV, Price DL, Mayeux R, Atack JR, Kellar KJ (1988) Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology 38:720–723
References
Beresini MH, Sadick MD, Galloway AL, Yen R, Yeh SH, Chang AC, Shelton DL, Wong WLT (1997) Assays for small molecule agonists and agonists of the neurotrophin receptors. In: Devlin JP (ed) High Throughput Screening. The Discovery of Bioactive Substances. Marcel Dekker Inc., New York, Basel, pp 329–343
Choi DW, Koh JY, Peters S (1988) Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci 8:185–195
Dichter MA (1986) The pharmacology of cortical neurons in tissue culture. In: Electrophysiological Techniques in Pharmacology, Alan R. Liss, Inc., pp 121–147
Furukawa S, Furukawa Y, Akazawa S, Satoyoshi E, Itoh K, Hayashi K (1983) A highly sensitive enzyme immunoassay for mouse β nerve growth factor. J Neurochem 40:734–744
Furukawa S, Furukawa Y, Satoyoshi E, Hayashi K (1986) Synthesis and secretion of nerve growth factor by mouse astroglial cells in culture. Biochem Biophys Res Commun 136:57–63
Furukawa S, Furukawa Y, Satoyoshi E, Hayashi K (1987) Regulation of nerve growth factor synthesis/secretion by catecholamine in cultured mouse astroglial cells. Biochem Biophys Res Commun 147:1048–1054
Graeber MB, Kreutzberg GW (1986) Astrocytes increase in glial fibrillary acidic protein during retrograde changes of facial motor neurons. J Neurocytol 15:363–373
Hefti F (1986) Nerve growth factor promotes survival of septal cholinergic neurons after fibrial transsections. J Neurosci 6:2155–2162
Höglinger GU, Sautter J, Meyer M, Spengler C, Seiler RW, Oertel WH, Widmer HR (1998) Rat fetal ventral mesencephalon grown as a solid tissue culture: influence of culture time and BDNF treatment on dopamine neuron survival and function. Brain Res 813:313–322
Horton CD, Qi Y, Chikaraishi D, Wang JKT (2001) Neurotrophin-3 mediates the autocrine survival of the catecholaminergic CAD CNS neuronal cell line. J Neurochem 76:201–209
Kinoshita A, Yamada K, Hayakawa T (1991) Human recombinant superoxide dismutase protects primary cultured neurons against hypoxic injury. Pathobiol 59:340–344
Koh JY, Choi DW (1988) Vulnerability of cultured cortical neurons to damage by excitotoxins: Differential susceptibility of neurons containing NADPH-diaphorase. J Neurosci 8:2153–2163
Krieglstein J, Brungs H, Peruche B (1988) Cultured neurons for testing cerebroprotective drug effects in vitro. J Pharmacol Meth 20:39–46
Kromer LF (1987) Nerve growth factor treatment after brain injury prevents neuronal death. Science 235:214–216
Lärkfors L, Ebendal T (1987) Highly sensitive immunoassays for β-nerve growth factor. J Immunol Meth 97:41–47
Matsumoto T, Oshima K, Miyamoto A, Sakurai M, Goto M, Hayashi S (1990) Image analysis of CNS neurotrophic factor effects on neuronal survival and neurite outgrowth. J Neurosci Meth 31:153–162
Oberpichler-Schwenk H, Krieglstein J (1994) Primary cultures of neurons for testing neuroprotective drug effects. J Neural Transm (Suppl) 44:1–20
Ogura A, Miyamoto M, Kudo Y (1988) Neuronal death in vitro: parallelism between survivability of hippocampal neurons and sustained elevation of cytosolic Ca2+ after exposure to glutamate receptor agonist. Exp Brain Res 73:447–458
Peruche B, Krieglstein J (1991) Neuroblastoma cells for testing neuroprotective drug effects. J Pharmacol Meth 26:139–148
Peruche B, Ahlemeyer B, Brungs H, Krieglstein J (1990) Cultured neurons for testing antihypoxic drug effects. J Pharmacol Meth 23:63–77
Prehn JHM, Backhauß C, Krieglstein J (1993) Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J Cerebr Blood Flow Metab 13:521–525
Prehn JHM, Lippert K, Krieglstein J (1995) Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury? Eur J Pharmacol 292:179–189
Qi Y, Wang J, McMillan M, Chikaraishi D (1997) Characterization of a CNS cell line CAD, in which morphological differentiation is initiated by serum deprivation. J Neurosci 17:1217–1225
Saragovi HU, Gehring K (2000) Development of pharmacological agents for targeting neurotrophins and their receptors. Trends Pharmacol Sci 21:93–98
Semkowa I, Schilling M, Heinrich-Noak P, Rami A, Krieglstein J (1996) Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res 711:44–54
Shinoda I, Furukawa Y, Furukawa S (1990) Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial cells. Biochem Pharmacol 39:1813–1816
Shinpo K, Kikuchi S, Morikawa F, Tashiro K (1999) Protective effects of the TNF-ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons. Brain Res 819:170–173
Shu X-Q; Mendell M (1999) Neurotrophins and hyperalgesia. Proc Natl Acad Sci 96:7693–7696
Thoenen H, Barde YA (1980) Physiology of nerve growth factor. Physiol Rev 60:1284–1355
White HS, Harmsworth WL, Sofia RD, Wof HH (1995) Felbamate modulates the strychnine-insensitive receptor. Epilepsy Res 20:41–48
Williams LR, Varon S, Peterson GM, Wictorin K, Fischer W, Bjorklund A, Gage FH (1986) Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transsection. Proc Natl Acad Sci USA 83:9231–9235
Yankner BA, Shooter EM (1982) The biology and mechanism of action of nerve growth factor. Ann Rev Biochem 51:845–968
Yu ACH, Hertz E, Hertz L (1984) Alterations in uptake and release rates for GABA, glutamate, and glutamine during biochemical maturation of highly purified cultures of cerebral neurons, a GABAergic preparation. J Neurochem 42:951–960
References
Banati RB, Rothe G, Valet G, Kreutzberg GW (1991) Respiratory burst in brain macrophages: a flow cytometric study on cultured brain macrophages. Neuropath Appl Neurobiol 17:223–230
Banati RB, Schubert P, Rothe G, Rudolphi K, Valet G, Kreutzberg GW (1994) Modulation of intracellular formation of reactive oxygen intermediates in peritoneal macrophages and microglial/brain macrophages by propentofylline. J Cerebr Blood Flow Metab 14:145–149
Bellavite P (1988) The superoxide-forming enzymatic system of phagocytes. Free Rad Biol Med 4:255–261
Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A (1987) Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells. Eur J Immunol 17:1271–1278
Giulian D, Baker TJ (1986) Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6:2163–2178
Rothe G, Valet G (1994) Flow cytometric assays of oxidative burst activity in phagocytes. Meth Enzymol 233:539–548
Rothe G, Oser A, Valet G (1988) Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes. Naturwissensch 75:354–355
References
Netto CA, Izquierdo I (1985) On how passive is inhibitory avoidance. Behav Neural Biol 43:327–330
References
Abdel-Hafez AA, Meselhy MR, Nakamura N, Hattori M, Watanabe H, Murakami Y, El-Gendy MA, Mahfouz NM, Mohamed TA (1998) Effects of paeoniflorin derivates on scopolamine-induced amnesia using a passive avoidance task in mice. Biol Pharm Bull 21:1174–1179
Chorover SL, Schiller PH (1965) Short-term retrograde amnesia in rats. J Comp Physiol Psychol 59:73–78
Dilts SL, Berry CA (1967) Effect of cholinergic drugs on passive avoidance in the mouse. J Pharmacol Exp Ther 158:279–285
Dunn RW, Flanagan DM, Martin LL, Kerman LL, Woods AT, Camacho F, Wilmot CA, Cornfeldt ML, Effland RC, Wood PL, Corbett R (1992) Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents. Eur J Pharmacol 214:207–214
Hudspeth WJ, McGaugh JL, Thomson CW (1964) Aversive and amnesic effects of electroconvulsive shock. J Comp Physiol Psychol 57:61–64
Jarvik ME, Essmann WB (1960) A simple one-trial learning situation in mice. Psychol Rep 6:290
Kubanis P, Zornetzer SF (1981) Age-related behavioral and neurobiological changes: A review with emphasis on memory. Behav neural Biol 31:115–172
Lien EJ (1993) Design and discovery of new drugs by stepping-up and stepping-down approaches. Progr Drug Res 40:63–189
Zornetzer SF, Thompson R, Rogers J (1982) Rapid forgetting in aged rats. Behav Neural Biol 36:49–60
References
Banfi S, Cornelli U, Fonio W, Dorigotti L (1982) A screening method for substances potentially active on learning and memory. J Pharmacol Meth 8:255–263
Fekete M, deWied D (1982) Potency and duration of action of the ACTH4–9 analog (ORG 2766) as compared to ACTH4–10 and [d-Phe7]ACTH4–10 on active and passive avoidance behavior of rats. Pharmacol Biochem Behav 16:387–392
Fine A, Dunnett SB, Björklund A, Iversen SD (1985) Cholinergic ventral forebrain grafts into the neocortex improve passive avoidance memory in a rat model of Alzheimer disease. Proc Natl Acad Sci USA 82:5227–5230
Fisher A, Brandeis R, Karton I, Pittel Z, Gurwitz D, Haring R, Sapir M, Levy A, Heldman E (1991) (±)-cis-2-Methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease. J Pharmacol Exp Ther 257:392–403
Hock FJ (1994) Involvement of nitric oxide-formation in the action of losartan (DUP 753): effects in an inhibitory avoidance model. Behav Brain Res 61:163–167
Hock FJ, McGaugh JL (1985) Enhancing effects of Hoe 175 on memory in mice. Psychopharmacology 86:114–117
Hock FJ, Gerhards HJ, Wiemer G, Stechl J, Rüger W, Urbach H (1989) Effects of the novel compound, Hoe 065, upon impaired learning and memory in rodents. Eur J Pharmacol 171:79–85
Jarvik ME, Kopp R (1967) An improved one-trial learning situation in mice. Psychol Rep 21:221–224
King RA, Glasser RL (1970) Duration of electroconvulsive shock-induced retrograde amnesia in rats. Physiol Behav 5:335–339
Picciotto MR, Zoli M, Léna C, Bessis A, Lallemand Y, Le Novère N, Vincent P, Pich EM, Brûlet P, Changeux JP (1995) Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374:65–67
Rush DK, Streit K (1992) Memory modulation with peripherally acting cholinergic drugs. Psychopharmacology 106:375–382
Wan R, Diamant A, de Jong W, de Wied D (1990) Changes in heart rate and body temperature during passive avoidance behavior in rats. Physiol Behav 47:493–499
References
Banfi S, Cornelli U, Fonio W, Dorigotti L (1982) A screening method for substances potentially active on learning and memory. J Pharmacol Meth 8:255–263
Bures J, Buresova O (1963) Cortical spreading depression as a memory disturbing factor. J Comp Physiol Psychol 56:268–272
Gouret C, Raynaud G (1976) Utilisation du test de la boite a deux compartiments pour la recherche de substances protégeant le rat contre l'amnésie par hypoxie: Intérèt at limites de la méthode. J Pharmacol (Paris) 7:161–175
Kurtz KH, Pearl J (1960) The effect of prior fear experience on acquired-drive learning. J Comp Physiol Psychol 53:201–206
References
Staubli U, Huston JP (1978) Up-hill avoidance: A new passive avoidance task. Physiol Behav 21:775–776
References
Brioni JD (1993) Role of GABA during the multiple consolidation of memory. Drug Dev Res 28:3–27
Decker MW, Tran T, McGaugh JL (1990) A comparison of the effects of scopolamine and diazepam on acquisition and retention of inhibitory avoidance in mice. Psychopharmacology 100:515–521
Fine A, Dunnett SB, Bjorklund A, Iversen SD (1985) Cholinergic ventral forebrain grafts into the neocortex improve passive avoidance memory in a rat model of Alzheimer's disease. Proc Natl Acad Sci, USA 82:5227–5230
Hepler DJ, Wenk G, Cribbs BL, Olton DS, Coyle JT (1985) Memory impairments following basal forebrain lesions. Brain Res 346:8–14
Kameyama T, Nabeshima T, Kozawa T (1986) Step-down-type passive avoidance-and escape-learning method. J Pharmacol Meth 16:39–52
Tomaz C, Dickinson-Anson H, McGaugh JL (1992) Basolateral amygdala lesions block diazepam-induced anterograde amnesia in an inhibitory avoidance task. Proc Natl Acad Sci USA 89:3615–3619
References
Braida D, Paladini E, Griffini P, Lamperti M, Colibretti L, Sala M (1998) Long-lasting antiamnesic effect of a novel anticholinesterase inhibitor (MF268). Pharmacol Biochem Behav 59:897–901
Dilts SL, Berry CA (1976) Effects of cholinergic drugs on passive avoidance in the mouse. J Pharmacol Exper Ther 158:279–285
Drachman DA, Leavitt J (1974) Human memory and the cholinergic system. Arch Neurol 30:113–121
Glick SD, Zimmerberg B (1972) Amnesic effects of scopolamine. Behav Biol 7:245–254
Iversen SD (1998) Behavioural Pharmacology of Dementia. Naunyn Schmiedeberg's Arch Pharmacol 358, Suppl 2, R 371
Lenègre A, Chermat R, Avril I, Stéru L, Porsolt RD (1988) Specificity of piracetam's anti-amnesic activity in three models of amnesia in the mouse. Pharmacol Biochem Behav 29:625–629
Nabeshima T, Kozawa T, Furukawa H, Kameyama T (1986) Phencyclidine-induced retrograde amnesia in mice. Psychopharmacology 89:334–337
Porsolt RD, Lenègre A, Avril I, Doumont G (1988) Antagonism by exifone, a new cognitive enhancing agent, of the amnesias induced by four benzodiazepines in mice. Psychopharmacology 95:291–297
Schindler U, Rush DK, Fielding S (1984) Nootropic drugs: Animal models for studying effects on cognition. Drug Devel Res 4:567–576
Yamaoto T, Yatsugi SI, Ohno M, Furuya Y, Kitajima I, Ueki S (1990) Minaprine improves impairment of working memory induced by scopolamine and cerebral ischemia in rats. Psychopharmacology 100:316–322
References
Connor DJ, Langlais PJ, Thal LJ (1991) Behavioral impairment after lesions of the nucleus basalis by ibotenic acid and quisqualic acid. Brain Res 555:84
Dunnett SB, Whishaw IQ, Jones GH, Bunch ST (1989) Behavioral, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats. Neurosci 20:653–669
Fonnum F (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24:407–409
Fuji K, Hiramatsu M, Kameyama T, Nabeshima T (1993a) Effects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats. Eur J Pharmacol 236:411–417
Fuji K, Hiramatsu M, Hayashi S, Kameyama T, Nabeshima T (1993b) Effects of propentofylline, a NGF stimulator, on alterations in muscarinic cholinergic receptors induced by basal forebrain lesion in rats. Neurosci Lett 150:99–102
Harder JA, Maclean CJ, Alder JT, Francis PT, Ridley RM (1996) The 5-HT1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transsection in the marmoset. Psychopharmacology 127:245–254
Morris RGM (1981) Spatial localization does not require the presence of local cues. Learn Motitiv 12:239–260
References
Chandler MJ, DeLeo JA, Carney JM (1985) An unanesthetized-gerbil model of cerebral ischemia-induced behavioral changes. J Pharmacol Meth 14:137–146
Gibson GE, Pulsinelli W, Blass JP, Duffy TE (1981) Brain dysfunction in mild to moderate hypoxia. Am J Med 70:1247–1254
Levine S, Sohn D (1969) Cerebral ischemia in infant and adult gerbils. Arch Pathol 87:315–317
Lundy EF, Solik BS, Frank RS, Lacy PS, Combs DJ, Zelenok GB, D'Alecy LG (1986) Morphometric evaluation of brain infarcts in rats and gerbils. J Pharmacol Meth 16:201–214
Schindler U (1983a) The effect of graded cerebral ischemia on brain water content and learning ability in the Mongolian gerbil. J Cerebr Blood Flow Metab 3:S335–S336
Schindler U (1983b) The effect of graded cerebral ischemia on brain water content and learning ability in the Mongolian gerbil. J Cerebr Blood Flow Metab 3:S335–S336
Schindler U, Rush DK, Fielding S (1984) Nootropic drugs: Animal models for studying effects on cognition. Drug Devel Res 4:567–576
References
Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of Parkinsonism: Selective destruction of dopaminergic neurones in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci, USA, 80:4546–4550
Röltgen DP, Schneider JS (1994) Task persistence and learning ability in normal and chronic low dose MPTP-treated monkeys. Behav Brain Res 60:115–124
Schneider JS, Kovelowski CJ (1990) Chronic exposure to low doses of MPTP. Cognitive deficits in motor asymptomatic monkeys. Brain Res 519:122–128
Schneider JS, Sun Z Q, Röltgen DP (1993) Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low-does MPTP-treated monkeys. Brain Res 615:351–354
Schneider JS, Sun Z Q, Röltgen DP (1994a) Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys. Pharmacol Biochem Behav 48:235–240
Schneider JS, Sun Z Q, Röltgen DP (1994b) Effects of dihydrexidine, a full dopamine D-1 receptor agonist on delayed response performance in chronic low dose MPTP-treated monkeys. Brain Res 663:140–144
References
Brush FR (1971) Aversive Conditioning and Learning. Academic Press, New York and London
Campbell BA, Church RM (1969) Punishment and Aversive Behavior. Appleton-Century-Crofts, New York, NY
D'Amato MR (1970) Experimental Psychology: Methodology, Psychophysics and Learning. McGraw-Hill, New York, NY, pp 381–416
Herrnstein RJ (1969) Method and theory in the study of avoidance. Psychol Rev 76:49–69
References
Capaldi EJ, Capaldi ED (1972) Aversive learning situations: apparatus and procedures. In: Myers RD (ed) Methods in Psychobiology, Vol. 2, Academic Press, London and New York, NY, pp 59–81
Hock FJ, McGaugh JL (1985) Enhancing effects of Hoe 175 on memory in mice. Psychopharmacology 86:114–117
Munn NL (1950) Handbook of Psychological Research on the Rat. Houghton Mifflin, Boston, MA
Silverman P (1978) Conditioned avoidance of aversive stimuli. In: Animal behaviour in the laboratory. Chapman and Hall, London, pp 204–219
References
Capaldi EJ, Capaldi ED (1972) Aversive learning situations: apparatus and procedures. In: RD. Myers (ed), Methods in Psychobiology, Vol. 2, Academic Press, London and New York, NY, pp 59–81
Netto CA, Valente JT, Borges-Sobrinho JB, Lasevitz J, Tomaz CA (1991) Reversal of retrieval impairment caused by retroactive interference in a two-way active avoidance task in rats. Behav Neur Biol 55:114–122
Salmi P, Samualsson J, Ahlenius S (1994) A new computer-assisted two-way avoidance conditioning equipment for rats: behavioral and pharmacological validation. J Pharmacol Toxicol Meth 32:155–159
References
McKean DB, Pearl J (1968) Avoidance box for mice. Physiol Behav 3:795–796
Tenen SS (1966) An automated one-way avoidance box for the rat. Psychosom Sci 6:407–408
References
Gilbert RM (1969) Discrimination learning? In: Gilbert RM, Sutherland NS (eds) Animal Discrimination Learning. Academic Press, New York, NY and London, pp 455–498
Hurwitz HMB (1969) Discrimination learning under avoidance schedules. In: Gilbert RM, Sutherland NS (eds) Animal Discrimination Learning. Academic Press, New York, NY and London, pp 413–454
Siegel S (1969) Discrimination overtraining and shift behavior. In: Gilbert RM, Sutherland NS (eds) Animal Discrimination Learning. Academic Press, New York, NY and London, pp 187–213
Sutherland NS (1969) Outlines of a theory of visual pattern recognition in animals and man. In: Gilbert RM, Sutherland NS (eds) Animal Discrimination Learning. Academic Press, New York, NY and London, pp 385–411
References
Aspide R, Fresiello A, de Filippis G, Carnevale UA, Sadile AG (2000) Non-selective attention in a rat model of hyperactivity and attention deficit: subchronic methylphenidate and nitric oxide synthesis. Neurosci Biobehav Rev 24:59–71
Birke LIA, Archer J (1983) Some issues and problems in the study of animal exploration. In: Archer J, Birke L (eds) Exploration in animals and humans, Van Nostrand Reinhold, Berkshire, UK
Cerbone A, Sadile AG (1994) Behavioral habituation to spatial novelty in rats: interference and non-interference studies. Neurosci Biobehav Rev 18:497–518
Dai H, Krost M, Carey RJ (1995) A new methodological approach to the study of habituation: the use of positive and negative behavioral indices of habituation. J Neurosci Meth 62:169–174
File SE (1980) The use of social interaction as a method for detecting anxiolytic activity in chlordiazepoxide-like drugs. J Neurosci Meth 2:219–238
Frisch C, Dere E, de Souza Silva MA, Gödecke A, Schrader J, Huston JP (2000) Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase-deficient mouse together with monoamine changes in cerebellum and ventral striatum. J Neurosci 20:6694–6700
Gerlai R (1999) Ethological approaches in behavioral neuro-genetic research. In: Crusio WE, Gerlai RT (eds) Handbook of Molecular-Genetic Techniques for Brain and Behavior Research (Techniques in the Behavioral and Neural Sciences, Vol. 13). Elsevier Science B.V. New York, pp 605–613
Groves PM, Thompson RI (1970) Habituation: a dual-process theory. Psychol Rev 77:419–450
Hall CS (1936) Emotional behavior in the rat. III. The relationship between emotionality and ambulatory activity. J Comp Physiol Psychol 22:345–352
Lát J (1973) The analysis of habituation. Acta Neurobiol Exp 33:771–789
Schwarting RKW, Sedelis M, Hofele K, Auburger GW, Huston JP (1999) Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson's disease. Neurotox Res 1:41–56
Thiel CM, Müller CP, Huston JP, Schwarting RKW (1999) High vs low reactivity to a novel environment: Behavioral, pharmacological and neurochemical measures. Neuroscience 93:959–962
References
Barnes CA (1979) Memory deficits associated with senescence: a neurophysiological and behavioral study in rat. J Comp Physiol Psychol 93:74–104
Ingram KD, Spangler EL, Iijima S, Kuo H, Bresnahan EL, Greig NH, London ED (1994a) New pharmacological strategies for cognitive enhancement using a rat model of age-related impairment. Ann NY Acad Sci 717:16–32
Ingram KD, Spangler EL, Iijima S, Ikari H, Kuo H, Greig NH, London ED (1994b) Rodent models in memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesis. Life Sci 55:2037–2049
Lamberty Y, Gower AJ (1990) Age-related changes in spontaneous behavior and learning in NMRI mice from maturity to middle age. Physiol Behav 47:1137–1144
Sara SJ, Devauges V (1989) Idazoxan, an α-2 antagonist, facilitates memory retrieval in the rat. Behav Neural Biol 51:401–411
Siegel S (1969) Discrimination overtraining and shift behavior. In: Gilbert RM, Sutherland NS (eds) Animal Discrimination Learning, Academic Press, New York, NY, pp 187–213
References
Buresova O, Bures J, Oitzl M, Zahalka A (1985) Radial maze in the water tank: an aversively motivated spatial working memory task. Physiol Behav 34:1003–1005
Kesner R (1980) An attribute analysis of memory: the role of the hippocampus. Physiol Psychol 8:189–197
Kesner R (1986) Neurobiological views of memory, In: Martinez J, Kesner R (eds) Learning and Memory, Academic Press, Inc.: Orlando, pp 399–438
Levin ED (1988) Psychopharmacological effects in the radialarm maze. Neurosci Biobehav Rev 12:169–175
Olton DS (1983) Memory functions and the hippocampus. In: Seifert W (ed) Neurobiology of the Hippocampus. Academic Press, London, New York, pp 335–373
Olton DS, Samuelson RJ (1976) Remembrance of places passed: spatial memory in rats. J Exp Psychol An Behav Proc 2:97–116
Olton D, Walker J, Gage F (1978) Hippocampal connections and spatial discrimination. Brain Res 139:295–308
Olton DS, Becker J, Handelman G (1979) Hippocampus, space and memory. The Behavioral and Brain Sciences 2:313–365
Willig F, Palacios A, Monmaur P, Mhrazi M, Laurent J, Delacour J (1987) Short-term memory, exploration and locomotor activity in aged rats. Neurobiol Aging 8:393–403
References
Grüsser OJ, Klinke R. (eds) Pattern Recognition in Biological and Technical Systems. Springer-Verlag, Berlin (1971)
Munn NL Handbook of Psychological Research on the Rat. Houghton Mifflin, Boston, MA (1950)
Sutherland NS (1969) Outlines of a theory of visual pattern recognition in animals and man. In: Gilbert RM, Sutherland NS (eds) Animal Discrimination Learning. Academic Press, New York, NY, pp 385–411
Thompson R (1969) Localization of the ‘visual memory system’ in the white rat. J Comp Physiol Psychol 69:1–29
Thompson R, Huestis PW, Crinella FM, Yu J (1987) Further lesion studies on the neuroanatomy of mental retardation in the white rat. Neurosci Biobehav Rev 11:415–440
References
Brandeis R, Dachir S, Sapir M, Levy A, Fisher A (1990) Reversal of age-related cognitive impairments by an M1 cholinergic agent, AF102B. Pharmacol Biochem Behav 36:89–95
Brioni JD, Decker MW, Gamboa LP, Izquierdo I, McGaugh JL (1990) Muscimol injections in the medial septum impair spatial learning. Brain Res 522:227–234
Brioni JD, Arolfo MP, Jerusalinski D, Medina JH, Izquierdo I (1991) The effect of flumazenil on acquisition, retention and retrieval of spatial information. Behav Neural Biol 56:329–335
Buresova O, Krekule I, Zahalka A, Bures J (1985) On-demand platform improves accuracy of the Morris water maze. J Neurosci Meth 15:63–72
Decker MW, Majchrzak MJ, Anderson DJ (1992) Effects of nicotine on spatial memory deficits in rats with spatial lesions. Brain Res 572:281–285
Gallagher M, Burwell R, Burchinal M (1993) Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze. Behav Neurosci 107:618–626
Nabeshima T (1995) Trial to produce animal model of Alzheimer's disease by continuous infusion of β-amyloid protein into the rat cerebral ventricle. Jpn J Psychopharmacol 15:411–418
McNamara R, Skelton R (1993) The neuropharmacological and neurochemical basis of place learning in the Morris water maze. Brain Res Rev 18:33–49
Nitta A, Nabeshima T (1996) Experimental techniques for developing new drugs acting on dementia. Alzheimer's disease animal model induced by β-amyloid protein. Jpn J Psychopharmacol 16:85–90
Nitta A, Itoh A, Hasegawa T, Nabeshima T (1994) β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci Lett 170:63–66
Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Meth 11:47–60
Morris R, Anderson E, Lynch G, Baudry M (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist. Nature 319:774–776
Morris RGM (1981) Spatial localization does not require the presence of local cues. Learn Motitiv 12:239–260
Morris RGM (1989) Synaptic plasticity and learning: Selective impairment in rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5. J Neurosci 9:3040–3057
Rapp PR, Rosenberg RA, Gallagher M (1987) An evaluation of spatial information processing in aged rats. Behav Neurosci 101:3–12
References
Eichenbaum H, Otto T, Cohen NJ (1992) The hippocampus-what does it do? Behav. Neural Biol 57:2–36
Larson J, Lieu T, Petchpradub V, LeDuc B, Ngo H, Rogers GA, Lynch G (1995) Facilitation of olfactory learning by a modulator of AMPA receptors. J Neurosci 15:8023–8030
Lynch G, Stäubli U (1991) Possible contributions of long-term potentiation to the encoding and organization of memory. Brain Res Rev 16:204–206
Nigrosh BJ, Slotnik BM, Nevin JA (1957) Olfactory discrimination, reversal learning and stimulus control in rats. J Comp Physiol Psychol 89:285–194
Otto T, Schottler F, Stäubli U, Eichenbaum H, Lynch G (1991) Hippocampus and olfactory discrimination learning: effects of entorhinal cortex lesions on olfactory learning and memory in a successive-cue go-no-go task. Behav Neurosci 105:111–119
Ravel N, Vigouroux M, Elaagouby A, Gervais R (1992) Scopolamine impairs delayed matching in an olfactory task in rats. Psychopharmacology 109:439–443
Roman F, Han D, Baudry M (1989) Effects of two ACTH analogs on successive odor discrimination learning in rats. Peptides 10:303–307
Roman FS, Simonetto I, Soumireu-Mourat B (1993) Learning and memory of odor-reward association: selective impairment following horizontal diagonal band lesions. Behav Neurosci 107:72–81
Stäubli U, Ivy G, Lynch G (1984) Hippocampal denervation causes rapid forgetting of olfactory information in rats. Proc Natl Acad Sci, USA 81:5885–5887
Willer J, Gallagher M, Graham PW, Crooks GB Jr. (1992) N-methyl-D-aspartate agonist D-AVP selectively disrupts taste-potentiated odor aversion learning. Behav Neurosci 106:315–323
References
Bennett PC, Zhao W, Lawen A, Ng KT (1996) Cyclosporin A, an inhibitor of calcineurin, impairs memory formation in day-old chicks. Brain Res 730:107–117
Bennett PC, Singaretnam LL, Zhao L-Q, Lawen A, Ng KT (1998) Peptidyl-prolyl-cis/trans-isomerase activity may be necessary for memory formation. FEBS Lett 431:386–390
Bourne RC, Davies DC, Stewart MG, Csillag A, Cooper M (1991) Cerebral glycoprotein synthesis and long-term memory formation in the chick (Gallus domesticus) following passive avoidance training depends on the nature of the aversive stimulus. Eur J Neurosci 3:243–248
Clements MP, Bourne RC (1996) Passive avoidance learning in the day-old chick is modulated by GABAergic agents. Pharmacol Biochem Behav 53:629–634
Colombo PJ, Rivera DT, Martinez JL Jr., Bennett EL, Rosenzweig MR (1997) Evidence for localized and discrete roles for enkephalins during memory function in the chick. Behav Neurosci 111:114–122
Crowe SF, Shaw S (1997) Salbutamol overcomes the effect of the noradrenergic neurotoxin DSP-4 on memory function in the day-old chick. Behav Pharmacol 8:216–222
Deyo RA, Hittner JM (1995) Effects of the Ca2+ channel antagonist flunarizine on visual discrimination learning. Neurobiol Learn Memory 64:10–16
Gibbs ME, Barnett JM (1976) Drug effects on successive discrimination learning in young chickens. Brain Res Bull 1:295–299
Gibbs ME, Ng KT (1976) Psychobiology of memory: Towards a model of memory formation. Biobehav Res 1:113–136
Gibbs ME, Ng KT (1979) Neuronal depolarization and the inhibition of short-term memory formation. Physiol Behav 23:369–375
Gilbert DB, Patterson TA, Rose SPR (1989) Midazolam induces amnesia in a simple, one-trial, maze-learning task in young chicks. Pharmacol Biochem Behav 34:439–442
Hölscher Ch, Rose SPR (1992) In inhibitor of nitric oxide synthesis prevents memory formation in the chick. Neurosci Lett 145:165–167
Ng KT, O'Dowd BS, Rickard NS, Robinson SR, Gibbs ME, Rainey C, Zhao W-Q, Sedman GL, Hertz L (1997) Complex roles of glutamate in the Gibbs-Ng model of one-trial aversive learning in the new-born chick. Neurosci Behav Rev 21:45–54
Rickard NS, Ng KT, Gibbs ME (1994) A nitric oxide agonist stimulates consolidation of long-term memory in 1-day old chick. Behav Neurosci 108:640–644
Rose SPR, Stewart MG (1999) Cellular correlates of stages of memory formation in the chick following passive avoidance training. Behav Brain Res 98:237–243
Sandi C, Rose SPR (1994) Corticosteroid receptor antagonists are amnesic for passive avoidance learning in day-old chicks. Eur J Neurosci 6:1292–1297
Stamatakis A, Stewart MG, Dermon CR (1998) Passive avoidance learning involves α2-noradrenergic receptors in a day old chick-NeuroReport 9:1679–1683
Stephenson RM, Andrew RJ (1994) The effects of 5-HT receptor blockade on memory formation in the chick: Possible interactions between β-adrenergic and serotoninergic systems. Pharmacol Biochem Behav 48:971–975
Tiunova A, Anokhin K, Rose SPR, Mileusnic R (1996) Involvement of glutamate receptors, protein kinases, and protein synthesis in memory for visual discrimination in the young chick. Neurobiol Learn Memory 65:233–243
Tiunova A, Anokhin K, Rose SPR (1998) Two critical periods of protein and glycoprotein synthesis in memory consolidation for visual categorization learning in chicks. Learn Memory 2:401–410
Venero C, Sandi C (1997) Effects of NMDA and AMPA receptor antagonists on corticosterone facilitation of long-term memory in the chick. Eur J Neurosci 9:1923–1928
Zhao W, Sedman GL, Gibbs ME, Ng KT (1994) Effect of PKC inhibitors and activators on memory. Behav Brain Res 60:151–160
References
Chen P, Ghoneim PP; Gormezano I (1992) Sodium pentobarbital: Sensory and associative effects in classical conditioning of the rabbit nictitating membrane response. Psychopharmacology 107:365–372
Du W, Harvey JA (1996) The nitric oxide synthesis inhibitor L-name facilitates associative learning. Prog Neuro-Psychopharmacol Biol Psychiatry 20:1183–1195
Du W, Harvey JA (1997) Harmaline-induced tremor and impairment of learning are both blocked by dizocilpine in the rabbit. Brain Res 745:183–188
El-Zahaby HM, Ghoneim MM, Johnson GM, Gormezano I (1994) Effects of subanesthetic concentrations of isoflurane and their interactions with epinephrine on acquisition and retention of the rabbit nictitating membrane response. Anesthesiology 81:229–237
Ghoneim MM, Chen P, El-Zahaby HM, Block RI (1994) Ketamine: Acquisition and retention of classically conditioned responses during treatment with large doses. Pharmacol Biochem Behav 49:1961–1066
Ghoneim MM, El-Zahaby HM, Block RI (1999) Classical conditioning during nitrous oxide treatment: influence of varying the interstimulus interval. Pharmacol Biochem Behav 63:449–455
Gormezano I, Prokasy WF, Thompson RF (eds) Classical Conditioning: III. Behavioral, Physiological and Neurochemical Studies in the Rabbit. Hillsday NJ: Erlbaum
Harvey JA, Romano AG (1993) Harmaline-induced impairment of Pavlovian conditioning in the rabbit. J Neurosci 13:1616–1623
Kehoe EJ, Schreurs BG, Macrae M, Gormezano I (1995) Effects of modulating tone frequency, intensity, and duration on the classically conditioned rabbit nictitating membrane response. Psychobiology 23:103–115
Kirkpatrick-Steger K, Vander Linden S, Gormezano I (1991) Effects of MDA on classical conditioning of the rabbit nictitating membrane response. Pharmacol Biochem Behav 39:183–189
McEchron MD, Gormezano I (1991) Morphine's effect on differential serial compound conditioning and reflex modification of the rabbit's (Oryctolagus cuniculus) nictitating membrane response. Behav Neurosci 105:510–520
Marshall-Goodell B; Gormezano I (1991) Effects of cocaine on conditioning of the rabbit nictitating membrane response. Pharmacol Biochem Behav 39:503–507
Robinson GB, Port RL, Stillwell EJ (1993) Latent inhibition of the classically conditioned rabbit nictitating membrane response is unaffected by the NMDA antagonist MK801. Psychobiology 21:120–124
Romano AG, Harvey JA (1993) Enhanced learning following a single, acute dose of MDA. Pharmacol Biochem Behav 44:965–969
Scavio MJ, Scavio Clift P, Wills JC (1992) Post-training effects of amphetamine, chlorpromazine, ketamine, and scopolamine on the acquisition and extinction of the rabbit's conditioned membrane response. Behav Neurosci 106:900–908
Schindler CW, Harvey JA (1990) Use of classical conditioning procedures in behavioral pharmacology. Drug Dev Res 20:169–187
Sears LL; Steinmetz JE (1990) Haloperidol impairs classically conditioned nictitating membrane responses and conditioning-related cerebellar interpositus nucleus activity in rabbits. Pharmacol Biochem Behav 36:821–830
Solomon PR, Beal MF, Pendlebury WW (1988) Age-related disruption of classical conditioning: A model systems approach to age-related memory disorders. Neurobiol Aging 9:935–946
Solomon PR, Barth CL, Wood MS, Velazquez E, Groccia-Ellison ME, Yang B-Y (1995a) Age-related deficits in retention of classically conditioned nictitating membrane responses in rabbits. Behav Neurosci 109:18–23
Solomon PR, Wood MS, Groccia-Ellison ME, Yang B-Y, Fanelli RJ, Mervis RF (1995b) Nimodipine facilitates retention of the classically conditioned nictitating membrane response in aged rabbits over long retention intervals. Neurobiol Aging 16:791–796
Solomon PR, Groccia-Ellison ME (1996) Classic conditioning in aged rabbits: delay, trace, and long delay conditioning. Behav Neurosci 110:427–435
Welsh SE, Romano AG; Harvey JA (1998a) Effects of 5-HT (2A/2C) antagonists on associative learning in the rabbit. Psychopharmacology 137:157–163
Welsh SE, Kachelries WJ, Romano AG, Simansky KJ; Harvey JA (1998b) Effects of LSD, ritanserin, 8-OH-DPAT, and lisuride on classical conditioning in the rabbit. Pharmacol Biochem Behav 59:469–475
Woodruff-Pak DS, Coffin JM, Papka M (1994a) A substituted pyrrolidinone, BMY 21502, and classical conditioning of the nictitating membrane response in young and older rabbits. Psychobiology 22:312–319
Woodruff-Pak DS, Li Y-T, Kem WR (1994b) A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotine receptor binding in rabbit brain. Brain Res 645:309–317
Woodruff-Pak DS, Chi J, Li Y-T, Pak MH, Fanelli RJ (1997) Nimodipine ameliorates impaired eyeblink classical conditioning in older rabbits in the long-delay paradigm. Neurobiol Aging 18:641–649
References
Brown PL, Jenkins HM (1968) Auto-shaping of the pigeons keypeck. J Exp Anal Behav 11:1–8
O'Connell MF (1980) Autoshaping and food acquisition in mice: a genetic analysis. J Comp Physiol Psychol 94:1149–1159
Oscos A, Martinez JL, McGaugh JL (1988) Effects of post-training d-amphetamine on acquisition of an appetitive autoshaped lever press response in rats. Psychopharmacology 95:132–134
Sidman M, Fletcher FG (1968) A demonstration of autoshaping in monkeys. J Exp Anal Behav 11:307–309
Steckler T, Andrews JS, Marten P, Turner JD (1993) Effects of NBM lesions with two neurotoxins on spatial memory and autoshaping. Pharmacol Biochem Behav 44:877–889
Vanover KE, Barrett JE (1998) An automated learning and memory model in mice: pharmacological and behavioral evaluation of an autoshaped response. Behav Pharmacol 9:273–283
References
Bartus RT (1979a) Physostigmine and recent memory: Effects in young and aged non-human primates. Science 206:1087–1089
Bartus RT (1979b) Effects of aging on visual memory, sensory processing and discrimination learning in the non-human primate. In: Ordy JM, Brizzee K (eds) Aging. Vol. 10. Raven Press, New York, NY, pp 85–114
Bartus RT, Dean RL (1981) Age-related memory loss and drug therapy: Possible directions based on animal models. In: Enna SJ, Samorajski T, Beer B (eds) Aging Vol. 17. Raven Press New York, NY, pp 209–223
Cai J-X, Arnstein AFT (1997) Dose-dependent effects of the dopamine receptor agonists A77636 and SKF81297 on spatial working memory in aged monkeys. J Pharmacol Exp Ther 283:183–189
Dean RL, Loullis C, Bartus RT (1983) Drug effects in an animal model of memory deficits in the aged: implications for future clinical trials. In: Walker RF, Cooper RL (eds) Experimental and Clinical Interventions in Aging. Marcel Dekker, New York, NY, pp 279–303
Struble RG, Cork LC, Whitehouse PJ, Price DL (1982) Cholinergic innervation in neuritic plaques. Science 216:413–414
Wisniewski HM, Ghetti T, Terry RD (1973) Neuritic (senile) plaques and filamentous changes in aged Rhesus monkeys. J Neuropathol Exp Neurol 32:566–584
References
Akhondzadeh S, Stone TW (1995) Induction of a novel form of hippocampal long-term depression by muscimol: Involvement of GABAA but not glutamate receptors. Br J Pharmacol 115:527–533
Alger BE, Dhanjal SS, Dingledine R, Garthwaite J, Henderson G, King GL, Lipton P, North A, Schwartzkroin PA, Sears TA, Segal M, Whittingham TS, Williams J (1984) Brain slice methods. In: R. Dingledine (ed) Brain Slices, Plenum Press. New York, NY pp 381–437
Bashir ZI, Berreta N, Bortolotto ZA, Clark K, Davies CH, Frenguelli BG, Harvey J, Potier B, Collingridge GL (1994) NMDA receptors and long-term potentiation in the hippocampus. In: Collingridge GL, Watkins JC (eds) The NMDA Receptor. Second Ed. Oxford University Press, Oxford, New York, Tokyo, pp 294–312
Behnisch T, Reymann KG (1993) Co-activation of metabotropic glutamate and N-methyl-D-aspartate receptors is involved in mechanisms of long-term potentiation maintenance in rat hippocampal CA1 neurons. Neurosci 54:37–47
Bliss TVP, Lømo T (1973) Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 232:331–356
Dingledine RY, Dodd Y, Kelly JS (1980) The in vitro brain slice as a useful neurophysiological preparation for intracellular recording. J Neurosci Methods 2:323–362
Fujii S, Sekino Y, Kuroda Y, Sasaki H, Ito KI, Kato H (1997) 8-Cyclopentyltheophylline, an adenosine A1 receptor antagonist, inhibits the reversal of long-term potentiation in hippocampal CA1 neurons. Eur J Pharmacol 33:9–14
Kettenmann H, Grantyn R (eds) Practical electrophysiological methods. Wiley-Liss, New York, NY (1992)
Landfield PW, Deadwyler SA (eds) (1988) Long-term Potentiation: From Biophysics to Behavior. Alan R. Liss, Inc., New York, NY
McIlwain H, Rodnight R (1962) Preparing neural tissues for metabolic study in vitro. In: McIlwain H, Rodnight R (eds) Practical neurochemistry. Churchill Ltd. London, pp 109–133
Milner B (1972) Disorders of learning and memory after temporal lobe lesions in man. Clin Neurosurg 19:421–446
Misgeld U (1992) Hippocampal Slices. In: Kettenmann H, Grantyn R (eds) Practical electrophysiological methods. Wiley-Liss, New York, NY, pp 41–44
Oomura Y, Sasaki K, Li A, Yoshii H, Yago H, Kimura H, Tooyama I, Hanai K, Nomura Y, Yanaihara N (1996) Protection against impairment of memory and immunoreactivity in senescence-accelerated mice by acidic fibroblast growth factor. Ann New York Acad Sci 786:337–347
Scoville WB, Milner B (1957) Loss of recent memory after bilateral hippocampal lesions. J Neurol Neurosurg Psychiatry 20:11–21
Tanaka Y, Sakurai M, Hayashi S (1989) Effect of scopolamine and HP 029, a cholinesterase inhibitor, on long term potentiation in hippocampal slices of the guinea pig. Neurosci Lett 98:179–183
Teyler TJ (1980) Brain slice preparations: Hippocampus. Brain Res Bull 5:391–403
References
Bennett MC, Diamond DM, Stryker SL, Parks JK, Parker WD Jr. (1992) Cytochrome oxidase inhibition: A novel animal model of Alzheimer's disease. J Geriatr Psychiatry Neurol 5:93–101
Beukers M, Boddeke EWGM (1991) Pharmacology of long-term potentiation. A model for learning reviewed. Pharm Weekbl Sci Ed 13:7–12
Brioni JD (1993) Role of GABA during the multiple consolidation of memory. Drug Dev Res 28:3–27
Brucato FH, Levin ED, Mott DD, Lewis DV, Wilson WA, Swartzwelder HS (1996) Hippocampal long-term potentiation and spatial learning in the rat:: Effects of GABAB receptor blockade. Neurosci 74:331–339
Croll SD, Greene NA, Lindsay RM, Wiegand SJ (1997) Sodium azide-induced learning deficits in rats: Time course and corresponding pathology. Psychobiology 25:34–47
Davis S, Bliss TVP, Dutrieux G, Laroche S, Errington ML (1997) Induction and duration of long-term potentiation in the hippocampus of the freely moving mouse. J Neurosci Methods 75:75–80
Errington ML, Lynch MA, Bliss TVP (1987) Long-term potentiation in the dentate gyrus: induction and increased glutamate release are blocked by D(-)aminophosphonovalerate. Neurosci 20:279–284
Gutnikov SA, Gaffan D (1996) Systemic NMDA receptor antagonist CGP-40116 does not impair memory acquisition but protects against NMDA neurotoxicity in rhesus monkeys. J Neurosci 16:4041–4050
Hölscher Ch, McGlinchey L, Anwyl R, Rowan MJ (1997a) HFS-induced long-term potentiation and LSF-induced depotentiation in area CA1 of the hippocampus are not good models for learning. Psychopharmacology 130:174–182
Hölscher Ch, Anwyl R, Rowan M (1997b) Block of HFS-induced LTP in the dentate gyrus by 1S,3S-ACPD. Further evidence against LTP as a model of learning. NeuroReport 8:451–454
Jibiki I, Wakita S, Kubota T, Kurokawa F, Fukushima T, Yamaguchi N (1993) Haloperidol-induced blockade of induction of long-term potentiation in perforant path-dentate gyrus pathway in chronically prepared rabbits. Pharmacol Biochem Behav 46:847–852
Kubota T, Jibiki I, Fukushima T, Kurokawa K, Yamaguchi N (1994) Carbamazepine-induced blockade of induction of long-term potentiation in the perforant path-dentate gyrus pathway in chronically prepared rabbits. Neurosci Lett 170:171–174
Namgung U, Valcourt E, Routtenberg A (1995) Long-term potentiation in the intact mouse hippocampus. Brain Res 689:85–92
References
Antal A, Kovanecz I, Bodis-Wollner I (1994) Visual discrimination and P300 are affected in parallel by cholinergic agents in the behaving monkey. Physiol Behav 56:161–166
Caudle RM (1993) The demonstration of long latency potentials in the CA1 region of the rat hippocampal slice. Brain Res 613:247–250
Ikeda K, Egashira T, Yamashita J, Okoyama S (1995) Effect of vagal autotransplantation and bifemelane hydrochloride on cholinergic markers and event-related potential in rats with lesions of the nucleus basalis magnocellularis. Brain Res 688:171–183
Kaga K, Harrison JB, Butcher LL, Woolf NJ, Buchwald JS (1992) Cat ‘P300’ and cholinergic septohippocampal neurons: Depth recordings, lesions, and choline acetyltransferase immunohistochemistry. Neurosci Res 13:53–71
Swick D, Pineda JA, Foote SL (1993) Effects of systemic clonidine on auditory event-related potentials in squirrel monkeys. Brain Res Bull 33:79–86
Wang YP, Kawai Y, Nakashima K (1999) Rabbit P300-like potential depends on cortical muscarinic receptor activation. Neuroscience 89:423–427
Wirtz-Brugger F, McCormack K, Szewczak M, Fielding S, Connfeldt M (1986) P300 in anesthetized rat: possible model for detecting memory-enhancing drugs. Neurosci Abstr 193.4
Wirtz-Brugger F, Cornfeldt M, McCormack K Szewczak M Fielding S (1987) Effect of several CNS agents on P300 in rats. Neurosci Abstr 475.13
References
Barclay LL, Gibson GE, Blass PJ (1981) The string test: An early behavioral change in thiamine deficiency. Pharmacol Biochem Behav 14:153–157
Gibson GE, Blass JP (1976) Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycemia. J Neurochem 27:37–42
Gibson GE, Shimada M, Blass JP (1978) Alterations in acetylcholine synthesis and cyclic nucleotides in mild cerebral hypoxia. J Neurochem 31:757–760
Gibson GE, Pulsinelli W, Blass JP, Duffy TE (1981) Brain dysfunction in mild to moderate hypoxia. Am J Med 70:1247–1254
Gibson GE, Pelmas CJ, Peterson C (1983) Cholinergic drugs and 4-aminopyridine alter hypoxic-induced behavioral deficits. Pharmacol Biochem Behav 18:909–916
Hock FJ (1993) Effects of cromakalim on sodium nitrite intoxication. In: Elsner N, Heisenberg M (eds) Gene, Brain and Behaviour. Proceedings of the 21st Göttingen Neurobiology Conference. Georg Thieme Verlag, Stuttgart, 681
Peterson C, Gibson GE (1982) 3,4-Diaminopyridine alters acetylcholine metabolism and behavior during hypoxia. J Pharmacol Exp Ther 222:576–582
Schindler U, Rush DK, Fielding S (1984) Nootropic drugs: Animal models for studying effects on cognition. Drug Develop Res 4:567–576
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag
About this entry
Cite this entry
Vogel, H.G., Vogel, W.H., Schölkens, B.A., Sandow, J., Müller, G., Vogel, W.F. (2002). Drug effects on learning and memory1 . In: Vogel, H.G., Vogel, W.H., Schölkens, B.A., Sandow, J., Müller, G., Vogel, W.F. (eds) Drug Discovery and Evaluation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29837-1_7
Download citation
DOI: https://doi.org/10.1007/3-540-29837-1_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-42396-6
Online ISBN: 978-3-540-29837-3
eBook Packages: Springer Book Archive